Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1201326-81-9 | MDL No. : | MFCD16495880 |
Formula : | C8H9NO4S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OANIRYJPNCZNHW-UHFFFAOYSA-N |
M.W : | 215.23 | Pubchem ID : | 53429647 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 48.61 |
TPSA : | 81.71 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.41 cm/s |
Log Po/w (iLOGP) : | 1.21 |
Log Po/w (XLOGP3) : | 0.28 |
Log Po/w (WLOGP) : | 1.35 |
Log Po/w (MLOGP) : | -0.11 |
Log Po/w (SILICOS-IT) : | 0.53 |
Consensus Log Po/w : | 0.65 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.47 |
Solubility : | 7.29 mg/ml ; 0.0339 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.56 |
Solubility : | 5.96 mg/ml ; 0.0277 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.42 |
Solubility : | 0.816 mg/ml ; 0.00379 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | Stage #1: With 3-chloro-benzenecarboperoxoic acid In tetrahydrofuran at 20℃; for 0.25 h; Molecular sieve Stage #2: at 20℃; for 0.25 h; Molecular sieve |
General procedure: The reaction vessel was charged with the heteroaromatic malononitrile (1.0 equiv,prepared according to ref. 6) and the specified solvent (1 mL per0.12 mmol). It was stirred at r.t. and 4 Å molecular sieve was added. Anhydrous m-CPBA (1.5 equiv) solution was prepared by dissolving in the specified solvent (1 mL per 0.22 mmol) and drying over molecular sieves (4 Å) for 10 min. This solution was added to the reaction mixture which was subsequently stirred for 10 min. After adding the nucleophile, the reaction mixture was stirred at r.t. The reaction was finally quenched with aq sodium thiosulfate solution and extracted with CH2Cl2. The combined organics were washed twice with saturated aqueous solution of NaHCO3 and brine, dried over Na2SO4 and concentrated in vacuo. Further purification was carried out by preparative HPLC. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87.2% | Stage #1: With trimethylaluminum In toluene at 80 - 90℃; for 2 h; Stage #2: With hydrogenchloride In water; toluene |
(d) Preparation of N-(2-chlorophenyl)-5-(methylsulfonyl)picolinamide 5:2-Chloroaniline (1.20 g, 0.0093 mol) in toluene (20 mL) was added to trimethylaluminum (2.0 M 4.6 mL) then methyl 5-(methylsulfonyl)picolinate 4 (1.0 g, 4.65 mol) was added and the mixture was heated to 80-90°C for 2 h. The reaction mixture was cooled down and IN HC1 solution (10 mL) was added to be acidic. Dichloromethane (100 mL) was then added and the organic phase was further washed with water (100 mL) and dried over sodium sulfate. The solvent was removed and the residue was mixed with ether (50 mL) and stirred for 0.5 h. The solid was filtered and dried to give N-(2-chlorophenyl)-5-(methylsulfonyl)picolinamide 5 as a light yellow solid. Yield: 1.26 g, 87.2percent. 1H-NMR (300 Hz, CDCI3) δ (ppm): 10.6 (s, 1H), 9.21 (m, 1H), 8.62 (dd, 1H), 8.51 (dd, 1H), 8.46 (dd, 1H), 7.45 (dd, 1H),7.34 (td, 1H), 7.12 (td, 1H),3.20 (s, 3H). |
[ 918967-32-5 ]
Ethyl 5-(Methylsulfonyl)pyridine-2-carboxylate
Similarity: 0.97
[ 1256633-19-8 ]
Ethyl 3-(methylsulfonyl)picolinate
Similarity: 0.91
[ 1314406-40-0 ]
Ethyl 5-(Ethylsulfonyl)pyridine-2-carboxylate
Similarity: 0.90
[ 205873-28-5 ]
Methyl 5-(methylsulfonyl)-1H-indole-2-carboxylate
Similarity: 0.85
[ 220679-12-9 ]
Ethyl 5-(methylsulfonyl)-1H-indole-2-carboxylate
Similarity: 0.83
[ 1186663-48-8 ]
5-(Methylsulfonyl)picolinic acid
Similarity: 0.94
[ 918967-32-5 ]
Ethyl 5-(Methylsulfonyl)pyridine-2-carboxylate
Similarity: 0.97
[ 1186663-48-8 ]
5-(Methylsulfonyl)picolinic acid
Similarity: 0.92
[ 1256633-19-8 ]
Ethyl 3-(methylsulfonyl)picolinate
Similarity: 0.91
[ 1314406-40-0 ]
Ethyl 5-(Ethylsulfonyl)pyridine-2-carboxylate
Similarity: 0.90
[ 1186663-48-8 ]
5-(Methylsulfonyl)picolinic acid
Similarity: 0.94
[ 918967-32-5 ]
Ethyl 5-(Methylsulfonyl)pyridine-2-carboxylate
Similarity: 0.97
[ 1186663-48-8 ]
5-(Methylsulfonyl)picolinic acid
Similarity: 0.92
[ 1256633-19-8 ]
Ethyl 3-(methylsulfonyl)picolinate
Similarity: 0.91
[ 1314406-40-0 ]
Ethyl 5-(Ethylsulfonyl)pyridine-2-carboxylate
Similarity: 0.90